- Report
- September 2023
- 303 Pages
Global
From €4879EUR$5,292USD£3,950GBP
- Report
- June 2023
- 364 Pages
Global
From €4879EUR$5,292USD£3,950GBP
- Report
- May 2023
- 375 Pages
Global
From €4879EUR$5,292USD£3,950GBP
- Report
- September 2022
- 95 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- December 2022
- 78 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- March 2023
- 185 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- September 2022
- 110 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- May 2022
- 109 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- November 2020
- 217 Pages
Global
From €3818EUR$4,000USD£3,199GBP
- Report
- April 2020
- 182 Pages
Global
From €3818EUR$4,000USD£3,199GBP
- Report
- January 2024
- 213 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- September 2023
- 165 Pages
Global
From €2243EUR$2,350USD£1,879GBP
- Report
- June 2021
- 185 Pages
Global
From €3985EUR$4,175USD£3,338GBP
- Report
- August 2023
- 370 Pages
Global
From €2376EUR$2,490USD£1,991GBP
- Report
- January 2023
- 170 Pages
China
From €2376EUR$2,490USD£1,991GBP
- Report
- August 2022
- 382 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2021
- 306 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- April 2021
- 377 Pages
Global
From €3813EUR$3,995USD£3,195GBP
- Report
- February 2023
- 122 Pages
United States
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2021
Global
From €3579EUR$3,750USD£2,999GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more